Palatin Technologies Inc (PTN)

0.63
0.05 8.45
AMEX : Health Care
Prev Close 0.58
Open 0.58
Day Low/High 0.55 / 0.63
52 Wk Low/High 0.36 / 1.18
Volume 2.46M
Avg Volume 1.16M
Exchange AMEX
Shares Outstanding 85.93M
Market Cap 49.84M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Palatin Technologies Presents Bremelanotide Alcohol Interaction Study At International Society For The Study Of Women's Sexual Health Annual Meeting

Palatin Technologies Presents Bremelanotide Alcohol Interaction Study At International Society For The Study Of Women's Sexual Health Annual Meeting

Results of Phase 1 Study Demonstrate No Adverse Events When Bremelanotide is Combined with Ethanol

Insider Trading Alert - AEL, PTN And BSX Traded By Insiders

Insider Trading Alert - AEL, PTN And BSX Traded By Insiders

Stocks with insider trader activity include AEL, PTN and BSX

Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) shares are rising after the FDA approved the first treatment for low female libido earlier this week.

Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) shares are climbing after the FDA approved the first low female libido treatment yesterday.

Palatin Technologies Completes $30 Million Financing

Palatin Technologies Completes $30 Million Financing

$20 Million Equity and $10 Million Debt

Palatin Technologies (PTN) Strong On High Relative Volume Today

Palatin Technologies (PTN) Strong On High Relative Volume Today

Trade-Ideas LLC identified Palatin Technologies (PTN) as a strong on high relative volume candidate

Palatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatment

Palatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatment

Palatin Technologies (PTN) shares are up over 30% after an FDA advisory panel voted to approve a version of the company's low female libido treatment.

3 Stocks Under $10 to Trade for Breakouts

3 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

Palatin Announces Start Of Bremelanotide Phase 3 Program For Female Sexual Dysfunction

Palatin Announces Start Of Bremelanotide Phase 3 Program For Female Sexual Dysfunction

Triggers euro 2.5 Million (~$3 Million) Milestone Payment from Gedeon Richter